GlaxoSmithKline plans to place a tiny radio beacon on each bottle of its Trizivir HIV drug in order to track the movement of the bottles, in an effort to help block counterfeiting and theft. The silicon chip attached to the bottles will not be used to collect patient information, GSK said.

Related Summaries